Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes

PURPOSE: To investigate the efficacy, safety, and anatomical outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) treatment of retinopathy of prematurity (ROP). METHODS: We performed a retrospective review of intravitreal anti-VEGF (bevacizumab or ranibizumab) treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Ophthalmol
Main Authors: Kang, Hyun Goo, Choi, Eun Young, Byeon, Suk Ho, Kim, Sung Soo, Koh, Hyoung Jun, Lee, Sung Chul, Kim, Min
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Ophthalmological Society 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6288015/
https://ncbi.nlm.nih.gov/pubmed/30549468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3341/kjo.2018.0011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados